These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Parkinson's disease in the elderly: a long-term efficacy study of levodopa/benserazide combination therapy. Mondal BK; Mondal KN Pharmatherapeutica; 1986; 4(9):571-6. PubMed ID: 3094036 [TBL] [Abstract][Full Text] [Related]
5. [Results of prolonged treatment of Parkinson's disease with the L-dopa-benserazide combination]. Casacchia M; Barba C; Ruggieri S; Zamponi A; Agnoli A Riv Neurol; 1974; 44(5):303-30. PubMed ID: 4217465 [No Abstract] [Full Text] [Related]
6. The long-term effects of combining carbidopa with levodopa for Parkinson's disease. Lee MC; Lippert DM; Loewenson RB; Tolosa ES; Resch JA; Martin WE Trans Am Neurol Assoc; 1976; 101():262-4. PubMed ID: 829295 [No Abstract] [Full Text] [Related]
7. [Improved therapeutic response to L-dopa in Parkinson's disease, when combined with bromocriptine (author's transl)]. Ulm G Nervenarzt; 1981 Feb; 52(2):116-20. PubMed ID: 7219619 [No Abstract] [Full Text] [Related]
8. Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a major criterion for idiopathic Parkinson's disease diagnosis. Merello M; Nouzeilles MI; Arce GP; Leiguarda R Mov Disord; 2002 Jul; 17(4):795-8. PubMed ID: 12210878 [TBL] [Abstract][Full Text] [Related]